InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Spiegelman Daniel K, 董事. Director active across 2 companies, notably Myriad Genetics INC. Aggregated, 9 disclosures have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €442k. History available since 27 May 2021. The latest transaction was disclosed on 29 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Spiegelman Daniel K
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
16,634 股0Common StockSEC:0000950170-25-080456:0
3,788 股@ US$22.0411.1% 占其流量Common StockSEC:0001238403-24-000002:0
15,151 股0Common StockSEC:0001238403-23-000002:0
6,424 股@ US$19.25170.034% mcap18.8% 占其流量Common StockSEC:0001238403-22-000002:0
17,275 股0Common StockSEC:0001628280-22-016223:0
3,139 股@ US$30.517618.2% 占其流量Common StockSEC:0001238403-21-000008:0
12,848 股0Common StockSEC:0001238403-21-000006:0
7,142 股@ US$28.986738.4% 占其流量Common StockSEC:0001238403-21-000004:0
15,889 股0Common StockSEC:0001238403-21-000002:0
9 条申报中的 9 条
About Spiegelman Daniel K
Daniel K. Spiegelman is a Board Member at Myriad Genetics Inc. As a board member, he contributes to the governance of the company and strategic decision-making. His experience in the biotechnology sector allows him to provide valuable insights for the company's development. Daniel Spiegelman plays a key role in evaluating performance and growth opportunities.
